M. Porteus
Molecular Biology · 2003–2018
A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 16 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 109 citations into it; #2,488 of 17,773 by trust here, #2,484 by citations
Whom M. Porteus trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Porteus overall
- A. Klug
- Xiangdong Meng
- D. Carroll
- Marcus B. Noyes
- Morgan L. Maeder
- Michelle L. Christian
- Lihua Julie Zhu
- Holger Puchta
- F. Urnov
- Nathan D. Lawson
Papers from M. Porteus's perspective
Ordered by how strongly the researchers M. Porteus trusts endorse each paper. Same corpus, a different order for every researcher.
- Controlling the false discovery rate: a practical and powerful approach to multiple testing
- Highly efficient endogenous human gene correction using designed zinc-finger nucleases (Nature)
- LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 (Science)
- Stimulation of Homologous Recombination through Targeted Cleavage by Chimeric Nucleases (Molecular and Cellular Biology)
- Gene targeting using zinc finger nucleases (Nature Biotechnology)
- Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. (Science)
- Model-based Analysis of ChIP-Seq (MACS)
- Design and selection of novel Cys2His2 zinc finger proteins. (Annual Review of Biochemistry)
- Capturing Chromosome Conformation (Science)
- CTCF-Mediated Functional Chromatin Interactome in Pluripotent Cells (Nature Genetics)
Their papers
- Highly efficient endogenous human gene correction using designed zinc-finger nucleases (2005) — 1,689 citations
- Chimeric Nucleases Stimulate Gene Targeting in Human Cells (2003) — 766 citations
- Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification (2008) — 752 citations
- Gene targeting using zinc finger nucleases (2005) — 641 citations
- Activation of proto-oncogenes by disruption of chromosome neighborhoods (2015) — 954 citations
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human haematopoietic stem and progenitor cells (2018) — 671 citations
- Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells (2015) — 1,033 citations
- An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level (2013) — 640 citations
- CRISPR/Cas9 Beta-globin Gene Targeting in Human Hematopoietic Stem Cells (2016) — 737 citations